Beginning this year, the Ohio arbovirus surveillance update can be found on the ODH website at http://www.odh.ohio.gov/arboupdate . The table will be updated each Monday through mosquito season.
Ohio Mosquito-borne Disease Surveillance
June 18, 2018
Mosquito season is here. The Ohio Department of Health (ODH) Zoonotic Disease Program, in partnership with ODH Laboratory, local public health partners and sanitary district partners, collects and tests mosquitoes from many communities in Ohio as part of statewide mosquito-borne disease surveillance. This surveillance also includes monitoring for human and veterinary cases as well.
(TRENTON) – New Jersey Secretary of Agriculture Douglas H. Fisher today announced the United States Department of Agriculture’s National Veterinary Services Laboratory (NVSL) in Ames, Iowa has confirmed the finding of an exotic East Asian tick, also known as the longhorned tick or bush tick, on a farm in Hunterdon County on November 9. Initial identification was made by the Monmouth County Tick-borne Diseases Lab, located at Rutgers University and the Hunterdon County Division of Health. This tick is not known to be present in the U.S., although there are records of at least a dozen previous collections of this species in the country on animals and materials presented for entry at U.S. ports.
Courtesy of the CDC Morbidity and Mortality Weekly Report Nov 10th, 2017
Amy M. Schwartz, MPH1; Alison F. Hinckley, PhD1; Paul S. Mead, MD1; Sarah A. Hook, MA1; Kiersten J. Kugeler, PhD1 (View author affiliations)
Problem/Condition: Lyme disease is the most commonly reported vectorborne disease in the United States but is geographically focal. The majority of Lyme disease cases occur in the Northeast, mid-Atlantic, and upper Midwest regions. Lyme disease can cause varied clinical manifestations, including erythema migrans, arthritis, facial palsy, and carditis. Lyme disease occurs most commonly among children and older adults, with a slight predominance among males.
West Nile virus and other domestic arboviral activity — United States, 2017
Provisional data reported to ArboNET
Tuesday, October 3, 2017
West Nile virus (WNV) activity in 2017
As of October 3rd, 1,015 counties from 47 states and the District of Columbia have reported
WNV activity to ArboNET for 2017, including 45 states and the District of Columbia with
reported WNV human infections (i.e., disease cases or viremic blood donors) and two additional
states with reported WNV activity in non-human species only (i.e., veterinary cases, mosquito
pools, dead birds, or sentinel animals)
West Nile virus and other domestic arboviral activity — United States, 2017 Provisional data reported to ArboNET Tuesday, August 29, 2017
This update from the CDC Arboviral Disease Branch includes provisional data reported to ArboNET for January 1 – August 29, 2017 for West Nile virus and selected other nationally notifiable domestic arboviruses. Additional resources for ArboNET and arboviral diseases are provided on page 9.
West Nile virus (WNV) activity in 2017
As of August 29th, 740 counties from 45 states and the District of Columbia have reported WNV activity to ArboNET for 2017, including 35 states with reported WNV human infections (i.e., disease cases or viremic blood donors) and 10 additional states and the District of Columbia with reported WNV activity in non-human species only (i.e., veterinary cases, mosquito pools, dead birds, or sentinel animals)
“Zika virus used to treat aggressive brain cancer,” BBC News reports. Animal and laboratory research suggests a modified version of the virus could possibly be used to target and destroy cancerous cells.
The Zika virus was first discovered in 1947. It hit the headlines in 2016 when an epidemic of the virus began quickly spreading through parts of South and Central America.
The virus, spread by mosquitoes, rarely causes serious problems in adults. But it can lead to birth defects, specifically microcephaly (a small, not fully developed head), if a woman contracts the virus when pregnant.
The virus has the ability to cross from the blood into the brain, so researchers wanted to see if it could be used to treat a very aggressive type of brain cancer called glioblastoma.